A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab
出版年份 2011 全文链接
标题
A systematic review of the efficacy and safety outcomes of anti-VEGF agents used for treating neovascular age-related macular degeneration: comparison of ranibizumab and bevacizumab
作者
关键词
-
出版物
CURRENT MEDICAL RESEARCH AND OPINION
Volume 27, Issue 7, Pages 1465-1475
出版商
Informa Healthcare
发表日期
2011-05-31
DOI
10.1185/03007995.2011.585394
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- EXTEND-I: safety and efficacy of ranibizumab in Japanese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration
- (2010) Yasuo Tano et al. ACTA OPHTHALMOLOGICA
- Risks of Mortality, Myocardial Infarction, Bleeding, and Stroke Associated With Therapies for Age-Related Macular Degeneration
- (2010) Lesley H. Curtis ARCHIVES OF OPHTHALMOLOGY
- HIGH-MOLECULAR-WEIGHT AGGREGATES IN REPACKAGED BEVACIZUMAB
- (2010) Malik Y Kahook et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial
- (2009) Manju L. Subramanian et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data
- (2009) Joseph S. Ross ARCHIVES OF INTERNAL MEDICINE
- Improved Vision-Related Function After Ranibizumab vs Photodynamic Therapy
- (2009) Neil M. Bressler ARCHIVES OF OPHTHALMOLOGY
- Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials
- (2009) P Mitchell et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- A randomised trial of bevacizumab and reduced light dose photodynamic therapy in age-related macular degeneration: the VIA study
- (2009) M. J. Potter et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Clinical safety of ranibizumab in age-related macular degeneration
- (2009) Ursula Schmidt-Erfurth Expert Opinion On Drug Safety
- Randomised clinical trial of intravitreal Avastin vs photodynamic therapy and intravitreal triamcinolone: long-term results
- (2009) S Sacu et al. EYE
- A systematic review on the effect of bevacizumab in exudative age-related macular degeneration
- (2009) Christine Schmucker et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- A Phase IIIb Study to Evaluate the Safety of Ranibizumab in Subjects with Neovascular Age-related Macular Degeneration
- (2009) David S. Boyer et al. OPHTHALMOLOGY
- Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-related Macular Degeneration (FOCUS): Year 2 Results
- (2008) Andrew N. Antoszyk et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1
- (2008) Carl D. Regillo et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study
- (2008) G. Weigert et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Treatment of macular degeneration - controversy and hope
- (2008) S. J. McGimpsey et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Age-related macular degeneration and mortality from cardiovascular disease or stroke
- (2008) J S L Tan et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Age-Related Macular Degeneration
- (2008) Rama D. Jager et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
- (2008) David M. Brown et al. OPHTHALMOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now